Terms: = Uterine cancer AND MUC16, CA125, CA-125 AND Treatment
314 results:
1. Cervical clear cell carcinoma: Case report and literature review.
Su D; Song X; Wu F; Fan S; Li M
Medicine (Baltimore); 2024 Mar; 103(13):e37449. PubMed ID: 38552088
[TBL] [Abstract] [Full Text] [Related]
2. Metastasis of cervical cancer indicated by elevation of serum ca125 produced by mediastinal lymph nodes: a case report.
Honda KI; Miyama M; Nishii Y; Tasaka R; Nakano Y; Umesaki N; Fukuda T; Ichimura T; Yasui T; Sumi T
J Med Case Rep; 2024 Feb; 18(1):112. PubMed ID: 38402387
[TBL] [Abstract] [Full Text] [Related]
3. Effect of 3D laparoscopy versus traditional laparotomy on serum tumor markers and coagulation function in patients with early-stage endometrial cancer.
Chen H; Xu D; Yu Y; Huang J; Zhou Q; Wang Q
Clinics (Sao Paulo); 2024; 79():100337. PubMed ID: 38368841
[TBL] [Abstract] [Full Text] [Related]
4. Machine learning for prediction of concurrent endometrial carcinoma in patients diagnosed with endometrial intraepithelial neoplasia.
Levin G; Matanes E; Brezinov Y; Ferenczy A; Pelmus M; Brodeur MN; Salvador S; Lau S; Gotlieb WH
Eur J Surg Oncol; 2024 Mar; 50(3):108006. PubMed ID: 38342041
[TBL] [Abstract] [Full Text] [Related]
5. Ovarian clear cell carcinoma with uterine intramural recurrence: Case report of ovarian clear cell carcinoma with fertility sparing treatment.
Chang TY; Yeh CY; Yang CY; Lin WC; Huang CC; Hung YC
Taiwan J Obstet Gynecol; 2024 Jan; 63(1):90-94. PubMed ID: 38216278
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic Factors for uterine Sarcoma and Carcinosarcoma: Insights from a 10-Year Follow-Up Study.
Kotowicz B; Dańska-Bidzińska A; Fuksiewicz M; Nasierowska-Guttmejer A; Raczkiewicz D; Gujski M; Piątek S; Bidziński M
Med Sci Monit; 2023 Dec; 29():e941562. PubMed ID: 38058118
[TBL] [Abstract] [Full Text] [Related]
7. uterine incarceration: a rare diagnosis in non-pregnant women.
Cruz LT; Reis-de-Carvalho C; Ribeirinho AL
BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 38035678
[TBL] [Abstract] [Full Text] [Related]
8. Development and validation of prediction model for early warning of ovarian metastasis risk of endometrial carcinoma.
Zhao Q; Li Y; Wang T
Medicine (Baltimore); 2023 Oct; 102(41):e35439. PubMed ID: 37832099
[TBL] [Abstract] [Full Text] [Related]
9. The relationship between serum ca-125 level and recurrence in surgical stage I endometrial cancer patients.
Wu HH; Chou HT; Tseng JY; Chan IS; Chen YJ
J Chin Med Assoc; 2023 Nov; 86(11):1001-1007. PubMed ID: 37643918
[TBL] [Abstract] [Full Text] [Related]
10. Association of normalization of postoperative carbohydrate antigen 125 levels with treatment failure following uterine artery embolization for adenomyosis.
Liu S; Peng C; Wang Z; Zhou X; Zhang S; Li G; Yang B
J Obstet Gynaecol Res; 2023 Nov; 49(11):2753-2760. PubMed ID: 37614048
[TBL] [Abstract] [Full Text] [Related]
11. Intratumoral and peritumoral MRI radiomics nomogram for predicting parametrial invasion in patients with early-stage cervical adenocarcinoma and adenosquamous carcinoma.
Xiao ML; Fu L; Wei Y; Liu AE; Cheng JJ; Ma FH; Li HM; Li YA; Lin ZJ; Zhang GF; Qiang JW
Eur Radiol; 2024 Feb; 34(2):852-862. PubMed ID: 37610442
[TBL] [Abstract] [Full Text] [Related]
12. [Evaluation of the efficacy of GnRH-a pretreatment before total hysterectomy for adenomyosis patients: a propensity score matching analysis].
Chen MG; Zhao ML; Fu HL; Mao M; Wang Q; Guo RX
Zhonghua Fu Chan Ke Za Zhi; 2023 Aug; 58(8):589-594. PubMed ID: 37599256
[No Abstract] [Full Text] [Related]
13. Preoperative prediction of lymphovascular space invasion in endometrioid adenocarcinoma: an MRI-based radiomics nomogram with consideration of the peritumoral region.
Yan B; Jia Y; Li Z; Ding C; Lu J; Liu J; Zhang Y
Acta Radiol; 2023 Sep; 64(9):2636-2645. PubMed ID: 37312525
[TBL] [Abstract] [Full Text] [Related]
14. Effect of Mifepristone vs Placebo for treatment of Adenomyosis With Pain Symptoms: A Randomized Clinical Trial.
Che X; Wang J; Sun W; He J; Wang Q; Zhu D; Zhu W; Zhang J; Dong J; Xu J; Zheng F; Zhou J; Zhao W; Lin Q; Ye L; Zhao X; Xu Z; Chen Y; Wang J; Wu W; Zhai L; Zhou Y; Zheng J; Zhang X
JAMA Netw Open; 2023 Jun; 6(6):e2317860. PubMed ID: 37307001
[TBL] [Abstract] [Full Text] [Related]
15. Monitoring treatment Response, Early Recurrence, and Survival in uterine Serous Carcinoma and Carcinosarcoma Patients Using Personalized Circulating Tumor DNA Biomarkers.
Bellone S; McNamara B; Mutlu L; Demirkiran C; Hartwich TMP; Harold J; Yang-Hartwich Y; Siegel ER; Santin AD
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240216
[TBL] [Abstract] [Full Text] [Related]
16. Postoperative Adjuvant treatment in Women with Stage I Endometrial cancer: A Retrospective Study.
Fu P; Sun H; Zhou T; Cui P; Wang S; Liu R
Int J Clin Pract; 2023; 2023():4007616. PubMed ID: 37035519
[TBL] [Abstract] [Full Text] [Related]
17. Laparoscopic Management of Disseminated Peritoneal Leiomyomatosis.
Kriplani I; Kriplani A; Sharma S; Sodhi M; Jain N
J Minim Invasive Gynecol; 2023 Jun; 30(6):443-444. PubMed ID: 36934877
[TBL] [Abstract] [Full Text] [Related]
18. Application value of Ki67 and serum ca125 in the deep myometrial invasion of endometrial adenocarcinoma.
Qin L
BMC Cancer; 2023 Mar; 23(1):240. PubMed ID: 36918859
[TBL] [Abstract] [Full Text] [Related]
19. Expression and Release of Tumor Cell Tissue Factor Triggers Recurrent Thromboembolism in a Patient with Endometrial cancer.
Beckmann L; Lennartz M; Poch A; Holstein K; Bokemeyer C; Langer F
Hamostaseologie; 2023 Aug; 43(4):289-296. PubMed ID: 36863395
[TBL] [Abstract] [Full Text] [Related]
20. Long-Term Efficacy and Toxicity of Intensity-Modulated Radiotherapy in Bulky Cervical cancer.
Wang Y; Lo TT; Wang L; Hsu ST; Hwang SF; Lu CH; Sun L
Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36673916
[TBL] [Abstract] [Full Text] [Related]
[Next]
